The Vascular Effects of Exenatide Versus Metformin in Patients With Pre-Diabetes

Completed · Phase 4

Conditions studied: Impaired Glucose Tolerance

In brief

The purpose of this study is to compare the effects of exenatide versus metformin on vascular health with chronic (3-month) therapy and during a 2-hour period following a meal in patients with pre-diabetes. It is predicted that exenatide will improve vascular health to a greater degree compared to metformin.

Key facts

Study ID
NCT00546728
Run by
St. Paul Heart Clinic
People needed
50
Starts
2007-10-01
Expected to finish
2011-07-01
Last updated by the study team
2013-11-08

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.